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INTRODUCTION 
Ischemic colitis is an inflammatory disease caused by the 
lack of colonic blood supply.
1,2 Being one of the most com-
mon form of intestinal ischemias, ischemic colitis is mani-
fested with unspecific clinical symptoms such as acute abdom-
inal pain, diarrhea, or hematochezia. The major causes include 
hypotension due to dehydration or bleeding and decreased 
blood flow.
3 Ischemic colitis occurs mostly in the elderly be-
cause of age-related tortuosity of the colonic arteries and so on.
4 
Factors other than age include diseases of decreased blood 
flow; small vessel etiology due to underlying diseases such as 
thrombosis, hypertension, and diabetes mellitus, iatrogenic cau-
ses such as surgery, or drugs.
2,3 Drug, especially estrogen, has 
been reported as the cause of ischemic colitis in Western coun-
tries.
3,5,6 But in Korea, Estrogen is a very rare cause of ischemic 
colitis. We report a case of ischemic colitis with a review of lit-
erature, developing after taking combined oral contraceptives 
without particular comorbidity in a 26-year-old American fe-
male living in South Korea. 
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CASE REPORT
A 26-year-old foreign female visited the hospital for sudden 
occurrence of lower abdominal pain during sleep with more 
than 10 times of diarrhea, and 3 times of hematochezia. There 
was no specific finding from her past medical and social his-
tory. She is unmarried and has been working as an elementary 
school English teacher in South Korea for 2 years with gener-
ally good health. Blood pressure 130/90 mm Hg, pulse rate 
60/min, respiratory rate 20/min, body temperature 37.3ºC, 
height 173 cm, weight 99 kg, and body mass index (BMI) 33 
were measured at admission. Physical examination revealed 
acute ill looking appearance, with soft abdomen but tender-
ness on the lower abdomen. Complete blood count test show-
ed leukocyte 8,630/mm
3, hemoglobin 12.8/dL, and platelet co-
unt 210,000/mm
3. Blood chemistry was analyzed as total pro-
tein 7.2 g/dL, albumin 4.6 g/dL, total bilirubin 0.3 mg/dL, AST 
17 U/L, ALT 17 U/L, alkaline phosphatase 47 U/L, amylase 140 
U/L, lipase 43 U/L, blood urea nitrogen 10.9 mg/dL, creatinine 
0.9 mg/dL, ESR 10 mm/hr, and CRP 0.77 mg/dL. Blood coag-
ulation test revealed PT/aPTT of 10.7/24.2 seconds. Stool ex-
amination showed WBC 0-2/HPF and RBC 0-2/HPF, with ne-
gative culture result. Urine Pregnancy test was also negative. 
Abdominal computerized tomography taken on the day of ad-
mission showed small amount of ascites in the pelvic cavity and 
blood vessels were normal without unusual finding (Fig. 1). Sig-
moidoscopy on day 2 of admission revealed normal rectum 
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and sigmoid colon, but erythemas and petechias were found 
along the longitudinal axis from the descending colon to the sp-
lenic flexure. Transverse colon appeared normal (Fig. 2). Bi-
opsy was performed at the descending colon, which revealed 
loss of the surface epithelium, mucosal necrosis, and hyaliniz-
ation of lamina propria compatible with ischemic colitis (Fig. 3). 
The patient was managed conservatively with bowel rest, in-
travenous fluids, and empirical antibiotics. Symptoms of abdo-
minal pain, diarrhea, and hematochezia were relieved and 
the patient started soft diet on day 4 of admission, and she was 
discharged on day 5 of admission. After 2 months of asympto-
matic period, she visited the outpatient department again with 
the recurrence of abdominal pain and hematochezia. On re-
peated carefyl history taking, she gave drug history about tak-
ing combined oral contraceptives (mercilon; combined ethi-
nyl estradiol and desogestrel) since coming to Korea. Also she 
remembered intermittent abdominal pain without reasonable 
causes before the last hospitalization. The new onset abdomi-
nal pain recurred 2 days ago with hematochezia after restarting 
the use of oral contraceptives 1 month ago. We advised her to 
stop the use of oral contraceptives after explaining that it might 
be the possible cause of ischemic colitis. Symptoms improved 
after conservative care for a few days. She stopped using oral 
contraceptives thereafter. We confirmed by a phone call 6 mon-
ths later that she was faring well without any recurrence of ab-
dominal pain or hematochezia. 
A   B  
Fig. 1. Abdominal computed tomography findings. (A) It shows no obstruction of middle colic branch of superior mesenteric artery in the 
transaxial view. (B) It shows no obstruction of inferior mesenteric artery in the transaxial view.
A   B  
Fig. 2. Sigmoidscopic findings. (A, B) It shows longitudinal segmental hyperemic mucosa with hemorrhagic spot at descending colon.
Fig. 3. Pathologic finding of colonoscopic biopsy. The colonic mu-
cosa shows superficial mucosal necrosis with loss of surface epi-
thelium with hyalinization of lamina propria (H&E stain, ×400).CS Seon et al. 
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DISCUSSION
Ischemic colitis is caused by various predisposing factors 
including old age, hypotension and decreased blood flow due 
to diseases, cardiogenic thromboembolism, myocardial infarc-
tion, major cardiovascular surgery, hypercoagulable state, drugs, 
long-distance running, constipation, vasospasm, and snake ve-
nom.
2,3 The patient of this study was hard to find a reasonable 
cause of ischemic colitis because she did not have any risk fac-
tor and history taking was not sufficient enough to find the com-
bined oral contraceptives taking in unmarried person. Recur-
rent symptom onset made it possible to diagnose oral con-
traceptive related ischemic colitis. It could be said, therefore, 
that finding predisposing factors of ischemic colitis is the most 
important to prevent further recurrence. It is impossible and 
sometimes not necessary to inspect all the above mentioned 
causes for every ischemic colitis patients. Ischemic colitis in 
the elderly is rarely caused by hypercoagulable state, so the test 
of it is generally not recommended.
3 Younger patients, how-
ever, require tests on hypercoagulable state and detailed his-
tory taking for drugs.
Venous thrombosis caused by estrogen in oral contracep-
tives was first reported in the early 1960s.
7 In 1990s, it was re-
ported that women with genetic defects such as factor V Lei-
den mutation, prothrombin 20210A, and deficiency of anti-th-
rombin, protein C and protein S was more susceptible to ven-
ous thrombosis while using oral contraceptives.
8-10 Oral contra-
ceptives change the blood concentration of lots of proteins in-
volved in the coagulation.
11 It is not clear how these changes of 
coagulation-related factors clinically affect the venous throm-
bosis.
12 Based on the available studies, the mechanism of ve-
nous thrombosis caused by oral contraceptives could be ex-
plained by the activated protein C (APC) resistance.
12 The APC 
resistance is related to the blood concentration of protein S, a 
tissue factor pathway inhibitor, and has a positive relation with 
sex hormone binding globulin concentration.
12-14 Each oral con-
traceptives causes venous thrombosis at different frequencies. 
It was reported that the risk of venous thrombosis depends on 
the dose of estrogen before 1995.
12 It was reported later that 
progesterone involves in the development of venous throm-
bosis, leading to a new concept of ‘total estrogenicity’ combin-
ing the antiestrogenic effects of estrogen and progesterone.
15 
If the estrogen is fixed on a certain dose, the frequency of ven-
ous thrombosis depends on the combined progesterone, so that 
the 3rd (gestodene or desogestrel) and 4th (cyproterone acetate 
or drospirenone) generation of progesterone increase the risk 
of venous thrombosis 1.5-4 times higher than the 2nd gener-
ation progesterone (levonorgetrel).
12 Moreover, obese females 
have 2.4-times higher risk of thrombosis than females with the 
normal weight. Obese females taking oral contraceptives have 
the risk of developing thrombosis 24 times higher than nor-
mal weight females not taking oral contraceptives.
16 Our pa-
tient was taking combined oral contraceptives including deso-
gestrel, which causes venous thrombosis more often, and was 
obese with BMI value of 33, contributing the increased risk of 
thrombosis than normal weight female who were taking the 
same contraceptives. 
Patients manifest rapid onset of abdominal pain, tenderness 
around the affected bowel area, and mild to moderate hema-
tochezia, as in this case.
3 Any part of the colon could be in-
volved, but around 75% shows left colon lesion, 25% of them 
including splenic flexure.
17 Our case also showed typical de-
scending colon lesion including splenic flexure. The diagno-
sis of ischemic colitis is initially suspected by typical clinical 
presentation, but the clinical manifestations are similar with 
other various diseases, making it hard to diagnose only by clini-
cal suspicion. Computerized tomography is useful to exclude 
other diseases presenting similar symptoms but difficult to 
make a definite diagnosis. Colonoscopy, on the other hand, is 
more sensitive by inspecting the location, and mucosal chang-
es and getting biopsy, which are important in the diagnosis of 
ischemic colitis.
3 Our patient was also unable to be diagnosed 
as ischemic colitis by the abdominal computerized tomogra-
phy but sigmoidoscopy enabled the definite diagnosis.
Single linear ulcer along the longitudinal axis is a distinctive 
colonoscopic finding suggestive of ischemic colitis, along with 
other findings of pale, edematous, petechial mucosa to hemor-
rhagic nodule and gangrene appearing in various degrees. The 
histologic patterns of ischemic colitis include mucosal coagul-
ation necrosis and hemorrhage, neutrophil infiltration, and gr-
anulation tissue formation; these patterns are not specific for 
diagnosis but helpful for predicting the disease progression.
18,19 
This patient showed mucosal necrosis and hyalinization of la-
mina propria. Angiography is only helpful for the diagnosis of 
ischemic colitis caused by thrombosis. Accordingly, ischemic 
colitis should be diagnosed in combination of clinical manifes-
tations, radiologic images, and colonoscopic findings.
3
Treatment of ischemic colitis depends on the clinical man-
ifestations and colonoscopic findings. Most of patients with isc-
hemic colitis improve with conservative managements such 
as bowel rest, intravenous fluids, and empirical antibiotics. Some 
cases may require surgery for gangrenous colitis or stricture.
20 
Prognosis depends on the extent of injury and comorbidities, 
but around 85% of patients are improved within 1-2 days of 
conservative management and fully recovered within 2 weeks. 
About 20% of patients progress to a peritonitis requiring a sur-
gery. Our patient recovered with conservative management 
and did not have the recurrence of the disease after quitting the 
possible cause. This case represents the repetitive ischemic co-
litis due to the use of oral contraceptives in young healthy fe-132  Clin Endosc 2011;44:129-132
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male without comorbidity, suggesting the importance of pre-
cise history taking including oral contraceptives and other risk 
factors for thrombosis. 
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